AEMD — AETHLON MEDICAL INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 882291 ·
Last close
$2.45
Market Cap
$3.84M
52W High
$2.72
52W Low
$1.36
ADV30
418,216
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | — | -2,062,116 | -2,018,245 | 8,057,128 | 6,956,397 | 1,344,031 |
| Sep 2025 | 0 | — | -1,509,830 | -1,487,100 | 7,323,090 | 5,853,493 | 1,577,113 |
| Jun 2025 | 0 | — | -1,792,390 | -1,761,858 | 5,306,002 | 3,765,154 | 1,882,489 |
| Mar 2025 | 0 | — | -2,003,963 | -6,254,893 | 7,359,534 | 5,501,261 | 2,236,004 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-6,920,660
Investing CF
$0
Financing CF
$9,077,460
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-50.75
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-173,222,020
Inventory
—
Receivables
$218,314
ST Investments
—
EBIT TTM
$-11,404,915
Pretax Income TTM
$-11,522,097
Interest Exp TTM
—
Analysts
2
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Mar 2025 | 0 | -9,341,365 | -13,388,089 | 7,359,534 | 2,236,004 | — | -7,645,532 |
| Mar 2024 | 0 | -12,636,568 | -12,208,174 | 8,245,982 | 2,479,650 | — | -10,129,810 |
| Mar 2023 | 574,245 | -11,898,638 | -12,029,786 | 17,508,940 | 2,444,730 | — | -10,505,128 |
| Mar 2022 | 294,165 | -10,420,885 | -10,416,091 | 19,417,954 | 2,426,554 | — | -9,767,157 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.98
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TUTH | Standard Dental Labs Inc. | $3.88M | $0.12 | — |
| GCTK | Glucotrack, Inc. | $3.72M | $0.59 | — |
| SNOA | Sonoma Pharmaceuticals, Inc. | $3.68M | $1.06 | — |
| BTCY | BIOTRICITY INC. | $4.07M | $0.14 | — |
| GEGP | GOLD ENTERPRISE GROUP INC | $3.36M | $0.00 | — |
News headlines (Yahoo Finance, 1h cache)
Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness
2026-05-21 12:01 · Yahoo
AEMD: Hitting Key Milestones as Company Advances Clinical Study
2026-03-24 13:54 · Yahoo
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
2026-03-24 12:01 · Yahoo
OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, CEO and CFO of Aethlon Medical, and M. Marin, Senior Analyst at Zacks SCR
2026-03-18 15:46 · Yahoo
AEMD: Positive Takeaways From CEO Chat
2026-03-18 14:24 · Yahoo
Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale Initiatives
2026-03-13 16:02 · Yahoo
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
2026-03-13 12:35 · Yahoo
Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
2026-03-12 12:01 · Yahoo
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
2026-03-10 14:21 · Yahoo
Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th
2026-03-06 13:35 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.